For: | Song QB, Wang Q, Hu WG. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: A meta-analysis. World J Gastroenterol 2015; 21(14): 4365-4372 [PMID: 25892888 DOI: 10.3748/wjg.v21.i14.4365] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4365.htm |
Number | Citing Articles |
1 |
Chengren Zhang, Lili Liu, Yaochun Lv, Jingjing Li, Cong Cao, Jiyong Lu, Shuai Wang, Binbin Du, Xiongfei Yang. Chemotherapy plus panitumumab/cetuximab versus chemotherapy plus bevacizumab in wild-type KRAS/RAS metastatic colorectal cancer: a meta-analysis. Expert Review of Anticancer Therapy 2022; 22(12): 1333 doi: 10.1080/14737140.2022.2147512
|
2 |
Ge Yan, Mohamed E.M. Saeed, Sebastian Foersch, Jose Schneider, Wilfried Roth, Thomas Efferth. Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome. Oncotarget 2019; 10(20): 1918 doi: 10.18632/oncotarget.26727
|
3 |
Susana Olmedillas-López, Dennis César Lévano-Linares, Carmen Laura Aúz Alexandre, Luz Vega-Clemente, Edurne León Sánchez, Alejandro Villagrasa, Jaime Ruíz-Tovar, Mariano García-Arranz, Damián García-Olmo. Detection of <i>KRAS</i> G12D in colorectal cancer stool by droplet digital PCR. World Journal of Gastroenterology 2017; 23(39): 7087-7097 doi: 10.3748/wjg.v23.i39.7087
|
4 |
Siwen Liu, Rong Ma, Haixia Cao, Shaorong Yu, Dan Chen, Changwen Jing, Zhuo Wang, Junying Zhang, Jifeng Feng, Jianzhong Wu. Safety and efficacy of EFGR and VEGF signaling pathway inhibition therapy in patients with colorectal cancer: a meta-analysis*. Oncology and Translational Medicine 2019; 5(2): 80 doi: 10.1007/s10330-018-0321-1
|
5 |
Guodong Li, Jiangang Liu, Songwen Tan. Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/2280440
|
6 |
Mariarosaria Boccellino, Lucio Quagliuolo, Concetta Alaia, Anna Grimaldi, Raffaele Addeo, Giovanni Francesco Nicoletti, Richard Eric Kast, Michele Caraglia. The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity. Current Medical Research and Opinion 2016; 32(11): 1839 doi: 10.1080/03007995.2016.1211522
|